Shridhar Narayanan - Concepedia

Author

Shridhar Narayanan

AstraZeneca (India)ORCID

Also Known As

Narayanan Shridhar, S. NARAYANAN, S. Narayanan, S. Narayanan,, Shridhar Narayanan

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (India)Foundation for Neglected Disease Research Orchid Pharma (India)AstraZeneca (United Kingdom)SASTRA University

About

Shridhar Narayanan is an author at AstraZeneca (India) specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1K
2	Natural Sciences	8	8	563
3	Biochemistry	7	7	500
4	Engineering	2	2	70
5	Health Sciences	2	2	88

Shridhar Narayanan

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i> Pravin S. Shirude, Radha Krishan Shandil, C Sadler, Journal of Medicinal Chemistry PharmacotherapyAntimicrobial ChemotherapyPharmaceutical ChemistryScaffold Morphing EffortsDrug Resistance	2013	161
Discovery of Imidazo[1,2-<i>a</i>]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis Subramanyam J. Tantry, Shankar D. Markad, Vikas Shinde, Journal of Medicinal Chemistry Bioorganic ChemistryAntimicrobial ChemotherapyChemical BiologyPharmaceutical ChemistryDrug Resistance	2017	121
Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects Santosh Vishwakarma, L.R. Iyer, Milind M. Muley, International Immunopharmacology InflammationRheumatologyAnti-inflammatoryAutoimmune DiseaseAnti-rheumatic Effects	2013	120
Novel Resveratrol and 5-Fluorouracil Coencapsulated in PEGylated Nanoliposomes Improve Chemotherapeutic Efficacy of Combination against Head and Neck Squamous Cell Carcinoma Aarti Mohan, Shridhar Narayanan, Swaminathan Sethuraman, BioMed Research International	2014	110
1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis Monalisa Chatterji, Radha Krishan Shandil, M. R. Manjunatha, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionPharmacotherapyAntimicrobial ChemotherapyPharmaceutical ChemistryCompound 2	2014	108
GRC-6211, a New Oral Specific TRPV1 Antagonist, Decreases Bladder Overactivity and Noxious Bladder Input in Cystitis Animal Models Ana Charrua, Célia Duarte Cruz, Shridhar Narayanan, The Journal of Urology	2008	103
4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity Maruti Naik, Vaishali Humnabadkar, Subramanyam J. Tantry, Journal of Medicinal Chemistry	2014	93
Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents Pravin S. Shirude, Radha Krishan Shandil, M. R. Manjunatha, Journal of Medicinal Chemistry	2014	88
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate Shahul Hameed P, Suresh Solapure, Vikas Patil, Nature Communications	2015	73
Analgesic studies on total alkaloids and alcohol extracts of <i>Eclipta alba</i> (Linn.) Hassk. Mahesh Sawant, Jolly C. Isaac, Shridhar Narayanan Phytotherapy Research Pain MedicineAnalgesic StudiesAnalgesiaIsolated AlkaloidsMedicinal Chemistry	2004	67

Page 1